Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Biohit Forms China JV for Diagnostic Test

publication date: Jun 25, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Biohit Oyj, a Finnish diagnostics company, and Anhui Wisdom-Win Investment Co. will establish a JV to make and sell Biohit’s GastroPanel kits to the China market. GastroPanel is a non-invasive test for low levels of acid in the stomach. The disorder can be caused by H. pylori infection or dysfunction of the stomach mucosa (atrophic gastritis). Wisdom-Win will invest 20 million RMB ($3.2 million) for 60% ownership of the JV, while Biohit Oyj’s technology, valued at 13 million RMB, will earn it a 40% stake. More details....

Stock Symbol: (HEL: BIOBV)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners